Effect of intensive therapy of multiple factors intervention on vascular complications in type 2 diabetes

  • Wu Hanni
  • Zhang Shuling
  • Shen Di


The effects of intensive versus regular therapy on incidence and progress of microalbuminuria in type 2 diabetes were compared. During a follow-up of 3 years, 96 cases of diabetes mellitus were randomized to intensive and regular therapy groups. HbA1c goal was same in the two groups, but the goal of blood pressure (Bp) and lipid was more strict in the intensive therapy group than in the regular therapy group. There was statistically significant difference in the incidence and progression of vascular complications between the two groups. Logistic stepwise-regression analysis (odds ration, OR) showed that there was significant difference in the progression of nephropathy (OR 0.24, 95% CI 0.12–0.76), retinopathy (OR 0.38, 95% CI 0.16–0.88), peripheral neuropathy (OR 0.42, 95% CI 0.22–0.86) and autonomic neuropathy (OR 0.29, 95% CI 0.12–0.86) between the two groups (P<0.01). It was concluded that intensive blood glucose controlling could retard diabetic vascular complications. Intensive therapy of multiple factors interventions (controlling Bp, regulating blood lipid, improving microcirculation) could decrease various risk factors for diabetic vascular complications.

Key words

type 2 diabetes vascular complications multiple factors intervention intensive therapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shichiri M, Kishikawa H, Ohkubo Yet al. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care, 2000, 23 (Suppl 2): B21PubMedGoogle Scholar
  2. 2.
    Levin S R, Coburn J W, Abraira Cet al. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Diabetes Care, 2000, 23:1478PubMedCrossRefGoogle Scholar
  3. 3.
    Estacio R O, Jeffers B W, Gifford Net al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care, 2000, 23 (Suppl2): B54PubMedGoogle Scholar
  4. 4.
    United Kingdom Prospective Study (UKPDS) Group (1998). Intensive blood control with sulfonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352(9131): 837CrossRefGoogle Scholar
  5. 5.
    Timothy C F. Evolution of the joint national committee reports, 1988–1997. Evolution of the science of treating hypertension. Arch Intern Med, 1997, 157(21): 2401CrossRefGoogle Scholar
  6. 6.
    Lam K S, Cheng I K, Janus E Det al. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia, 1995, 38:604.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2003

Authors and Affiliations

  • Wu Hanni
    • 1
  • Zhang Shuling
    • 1
  • Shen Di
    • 1
  1. 1.Department of Endocrinology, Xiehe Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhan

Personalised recommendations